Vilazodone
Back to searchMolecule Structure
Scientific Name
Vilazodone
Description of the Drug
Vilazodone is an antidepressant agent used for the treatment of major depressive disorder that targets the 5-HT transporter and 5-HT1A receptors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06684
http://www.drugbank.ca/drugs/DB06684
Brand Name(s)
Not Available
Company Owner(s)
Alembic Pharmaceuticals Ltd, Invagen Pharmaceuticals Inc, Accord Healthcare Inc, Teva Pharmaceuticals Usa, Allergan Sales Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Serotonin 1a (5-HT1a) receptor | SINGLE PROTEIN | PARTIAL AGONIST | CHEMBL214 |
Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL650682 | ||
Human Metabolome Database | HMDB0015637 | ||
DrugBank | DB06684 | ||
PubChem: Thomson Pharma | 14930538 | ||
PubChem | 6918314 | ||
Mcule | MCULE-4401910184 | ||
LINCS | LSM-45389 | ||
Nikkaji | J829.149G | ||
PDBe | YG7 | ||
BindingDB | 50151982 | ||
DrugCentral | 4223 | ||
ChemicalBook | CB31011682 | ||
Guide to Pharmacology | 7427 | ||
rxnorm | VILAZODONE HYDROCHLORIDE | VILAZODONE | VIIBRYD |
ChEBI | 70707 | ||
ZINC | ZINC000001542113 |